section name header

Information

AHFS Class:

28:08.12 Opiate Partial Agonists


Generic Name

Products

Butorphanol tartrate is available in concentrations of 1 mg/mL (in 1-mL vials) and 2 mg/mL (in 1- and 2-mL single-use vials and 10-mL multidose [preserved] vials).2904; 2905

Each mL of solution also contains citric acid 3.3 mg, sodium citrate 7.29 mg (equivalent to sodium citrate anhydrous 6.4 mg),2904 and sodium chloride 6.4 mg.2904; 2905 Also present in the multidose vials is 0.1 mg/mL of benzethonium chloride as a preservative.2904

pH

From 3 to 5.5.2904

Administration

Butorphanol tartrate may be administered by intramuscular or intravenous injection.2904; 2905

Stability

Butorphanol tartrate injection should be stored at controlled room temperature and retained in the original carton to protect from light.2904; 2905

Central Venous Catheter

Butorphanol tartrate (Apothecon) 0.04 mg/mL in dextrose 5% was found to be compatible with the ARROWg+ard Blue Plus (Arrow International) chlorhexidine-bearing triple-lumen central catheter. Essentially complete delivery of the drug was found with little or no drug loss occurring. Furthermore, chlorhexidine delivered from the catheter remained at trace amounts with no substantial increase due to the delivery of the drug through the catheter.2335

Compatibility

Additive Compatibility

Drugs in Syringe Compatibility

Y-Site Injection Compatibility (1:1 Mixture)

Other Info

References

For a list of references cited in the text of this monograph, search the monograph titled References.

Copyrights

ASHP® Injectable Drug InformationTM. Selected Revisions March 31, 2024. © Copyright, 2024. American Society of Health-System Pharmacists®, 4500 East-West Highway, Suite 900, Bethesda, Maryland 20814.